Arcellx股票討論區

$Arcellx(ACLX.US)$ sell
$銘騰國際(MTEN.US)$ buy

See Biotech companies with cancer assets 👇
⇨ held by 5 biopharma-focused hedge funds! 🔥
$Arcellx(ACLX.US)$ : Anito-cel (Ph 2)
$Adaptimmune Therapeutics(ADAP.US)$ : Afami-cel (PDUFA) ⏳
$Bicycle Therapeutics(BCYC.US)$ : BT8009 (Ph 1/2)
$Centessa Pharmaceuticals(CNTA.US)$ : LB101 (Ph 1/2)
$Day One Biopharmaceuticals(DAWN.US)$ : Tovorafenib (PDUFA) (check comments for details)
$Fate Therapeutics(FATE.US)$ : FT576 (Ph 1)
$Fusion Pharmaceuticals(FUSN.US)$ : FPI-2265 (Ph 2)
$GRCL: ...

$寶潔(PG.US)$ Downgraded to Hold From Buy at Truist
Procter & Gamble Price Target Cut to $155.00/Share From $165.00 by Truist Securities.
Roth Capital Upgrades $實耐寶(SNA.US)$to Buy From Neutral, Adjusts Price Target to $298 From $278
Snap-On (SNA) has an average rating of hold and price targets ranging from $190 to $302, according to analysts polled by Capital IQ.
Truist Securities Initiates Coverage of $Arcellx(ACLX.US)$ ...

Gainers:
• $Akero Therapeutics(AKRO.US)$ +9.6% (announces two financing transactions with Pfizer (PFE) and Hercules Capital (HTGC) providing access to up to $125 million)
• $BrightSpire Capital(BRSP.US)$ +6.3% (increases dividend)
• $Humanigen(HGEN.US)$ +4% (entered into an agreement with PCI Pharma Services as part of preparations for commercialization in the United Kingdom)
• $艾里遜變速箱(ALSN.US)$ +2.8% (electric hybrid bu...

QUICK SCALP $ACLX — STOCK PLAY
NEED IT TO BREAK OVER: $22.24
key indicator for MORE uptrend $22.45
confirmation uptrend - $22.61
mini breakout - $22.86 $Arcellx(ACLX.US)$

$Arcellx(ACLX.US)$ 7以下抄底，止損6.7

$Arcellx(ACLX.US)$ 可以在10.5附近進場，止損5%